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ally develops in people with renal function 
disorders or due to exogen Mg intake for 
constipation. Hospitalized cases of fatal 
hypermagnesemia are rare in the litera-
ture. !e aim of this case report was to see 
if fatal progression could be due to delayed 
diagnose.
Case Presentation. A 61 year old woman 
presented at the emergency department 
(ED) for the evaluation of her symptoms 
which were leg pain, weakness, nausea, 
constipation and general debility. In her 
prior history, she had used magnesia cal-
cine for laxative until two weeks before. 
Electrocardiography showed atrial "-
brillation with high ventricular respond 
(HVRAF). Initial serum magnesium (Mg) 
concentration was 6.80 mEq/l. 10% cal-
cium gluconate with 20 ml used to antago-
nize symptoms for treatment. Intravenous 
(IV) metoprolol was used for HVRAF 
but the patient was unresponsive. On the 
second day Mg rose to 7.06 mEq/l. !e 
patient’s consciousness was altered, she 
developed lethargy, and hemodynamic in-
stability was revealed. In addition, respira-
tory distress was present and patient was 
intubated. !erefore, she was diagnosed 
with a suspected Mg intoxication due to 
laxative use. Continuous hemodia"ltration 
(CHDF) was urgently used to decrease Mg. 
On the third day the patient was unrespon-
sive to the treatment and died in intensive 
care unit (ICU). 
Conclusion. Patients with nonspeci"c 
symptoms due to a prolonged laxative use 
can be admitted to the ED. Hypotension, 
altering consciousness and cardiac dysthy-
mias can be revealed quickly and therefore 
the progress is fatal. Mg intoxication must 
be noticed early in the ED. IV calcium 
directly antagonises the e#ects of magne-
sium. It can reverse e#ects such as cardiac 
arrhythmias. IV normal saline must be 
used for supportive treatment and if those 
not responding to intravenous calcium and 
other supportive measures, CHDF must be 
used urgently for all patients with features 
of life threatening hypermagnesemia.
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INTRODUCTION
Hypermagnesemia generally develops in 
people with abnormal kidney functions 
or in those using exogen magnesium for 
constipation (1,2). Severe hypermagne-
semia is a rare clinical condition that o$en 
results with death in hospital. Because of 
previous symptoms such as altered con-
sciousness, vomiting interferes with early 
symptoms of hypermagnesemia. It can’t be 
noticed until fatal progression is present 
(3).Hypermagnesemia is characterized by 
the loss of progressive muscle strength and 
dysfunction of central nervous system and 
cardiovascular system. Clinical signs and 
symptoms such as sepsis, gut obstruction 
and "rst motor neuron diseases are non-
speci"c (4).Our aim at reporting this case 
was to show that an unnoticed hyperma-
gnesemia had been fatal at the emergency 
department (ED). 
CASE PRESENTATION
A 61 year old woman known for su#ering 
from schizophrenia presented at the ED 
for the evaluation of her symptoms which 
were leg pain, weakness, nausea, constipa-
tion and general debility. We learned that 
she had used magnesia calcine for laxative 
until two weeks before. 
Initially the patient’s Glasgow Coma Scale 
was 14,  blood pressure was 82/60 mmHg , 
heart rate was 148 beats/minute , respirato-
ry rate was 27 breaths/minute, temperature 
was 36,2 °C, oxygen saturation  88%  and 
"nger stick blood glucose was 139  mg/dl.
Physical examination "ndings were normal 
auscultation lung sounds, tachycardia, nor-
mal pupils, and lower extremity strength 
muscle 2/5, distended abdomen and de-
creased bowel sounds.
Radiographic signs were normal. Elec-
trocardiography (ECG) showed atrial "-
brillation with high ventricular respond 
(HVRAF). Initially, laboratory results were 
as follows; normal complete blood count, 
BUN: 32.91 mg/dl, creatinine (cre): 1.31 
mg/dl, magnesium (Mg): 6.80 mEq/l, po-
tassium: 5.66 mEq/l, calcium: 6.74 mEq/l. 
Hypocalcaemia was treated with 20 ml of 
10% calcium gluconate. Intravenous (IV) 
metoprolol was used for HVRAF. Normal 
saline, dopamine and noradrenalin IV 
infusion were started to improve perfu-
sion. !e following morning, the patient’s 
consciousness was altered, she developed 
lethargy, and hemodynamic instability was 
revealed. In addition, respiratory distress 
was present and patient was intubated.  !e 
patient’s condition worsened quickly and 
she developed shock and acute kidney fail-
ure. HVRAF was unresponsive to electrical 
and medical cardioversion. Serum Mg level 
rose to 7.06 mEq/l. !erefore, she was di-
agnosed with a suspected Mg intoxication 
due to laxative use. A nephrologist was then 
consulted for the treatment of symptomatic 
hypermagnesemia. Continuous hemodia-
"ltration (CHDF) was used to decrease Mg 
urgently. Following CHDF, laboratory re-
sults were BUN: 25.39 mg/dl, cre:0.96 mg/
dl and Mg:4.47 mEq/l respectively. Atrial 
"brillation didn’t improve and overdrive 
pacing was performed. On the third day the 
patient was transferred to ICU and hemo-
dynamic parameters became worse. Serum 
Mg level didn’t decrease and HRVAF didn’t 
improve. !e patient died in ICU.
SIGNA VITAE 2019; 15(2): 73-74
74   |  SIGNA VITAE
DISCUSSION
Normal serum Mg concentration is be-
tween 0.7-1.1 mmol/L. Kidneys provide 
autoregulation of serum Mg levels (5). Hy-
permagnesemia is a problem if an exces-
sive Mg intake or renal failure is present. 
Hypermagnesemia is de"ned as serum Mg 
levels over 1.5 mmol/L. Mg levels rise in 
plasma as kidney function decreases (6).
When exogenous Mg intake is given as 
antacids or laxatives at usual therapeutic 
doses especially in patients with renal fail-
ure, severe and symptomatic hypermagne-
semia can also be induced (7).
Mg intakes may be administered intrave-
nously, orally and  via rectal enema; hy-
permagnesemia can occur at usual thera-
peutic doses especially in patients with 
dysfunction in regulation of Mg levels 
(2,8,9).
Clinical symptoms are present when Mg 
levels are  over 2 mmol/L in plasma (6). 
A correlation is seen between plasma Mg 
levels and clinical presentation of hyper-
magnesemia (9–11).
Clinical correlations of plasma Mg levels 
are showed in Table 1.
Hypermagnesemia inhibits parathyroid 
hormone secretions and creates a decrease 
in calcium levels in plasma. Hypocalcae-
mia can cause of ECG changes (12).
Treatment of hypermagnesemia changes 
according to renal function and plasma 
Mg levels. Loop diuretics increase Mg 
excretion in patients who prevent renal 
functions or with mild or moderate re-
nal failure. Loop diuretics can be used for 
treatment of mild or moderate hyperma-
gnesemia but CDHF is needed in presence 
of neurological and cardiovascular symp-
toms for treatment of hypermagnesemia. 
In symptomatic patients, before CDHF, 
calcium is used to treat the symptoms (13).
CONCLUSION(S)
Patients with nonspeci"c symptoms due 
to a prolonged laxative use can be ad-
mitted to the ED. Hypotension, altering 
consciousness and cardiac dysthymias de-
velop quickly and, therefore, o$en results 
death in hospital. Mg intoxication must be 
noticed early in the ED. Iv calcium reverse 
cardiac arrhythmia, iv normal saline and 
CHDF must be used urgently.
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